Sugi Predict

Sugi Predict / Compounds / SCHEMBL7604772

SCHEMBL7604772

SCHEMBL7604772

CC1=NS(=O)(=O)c2cc(C)ccc2N1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.71
▸ LMNA P02545 1/20 0.71
▸ CYP1A2 P05177 1/20 0.71
▸ CYP3A4 P08684 1/20 0.71
▸ CYP2D6 P10635 1/20 0.71
▸ THRB P10828 1/20 0.71
▸ TSHR P16473 1/20 0.71
▸ ABCC8 Q09428 1/20 0.71
▸ KCNJ11 Q14654 1/20 0.71
▸ SMN1; SMN2 Q16637 1/20 0.71
▸ CA12 O43570 2/20 0.64
▸ CA1 P00915 2/20 0.64
▸ CA2 P00918 2/20 0.64
▸ CA9 Q16790 2/20 0.64
▸ CA4 P22748 1/20 0.51
▸ CA7 P43166 1/20 0.51
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ HSD17B10 Q99714 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7601849 0.86 CA1 (0.64) ALDH1A1LMNACYP1A2CYP3A4CYP2D6
Diazoxide SCHEMBL41255 0.83 ABCC8 (1.00) ALDH1A1LMNACYP1A2CYP3A4CYP2D6
SCHEMBL10724810 0.83 ALDH1A1 (0.67) ALDH1A1LMNACYP1A2CYP3A4CYP2D6
Diazoxide SCHEMBL31112206 0.83 ABCC8 (1.00) ALDH1A1LMNACYP1A2CYP3A4CYP2D6
SCHEMBL8286628 0.83 ALDH1A1 (0.67) ALDH1A1LMNACYP1A2CYP3A4CYP2D6
SCHEMBL28084847 0.83 ALDH1A1 (0.67) ALDH1A1LMNACYP1A2CYP3A4CYP2D6
SCHEMBL10727722 0.80 ABCC8 (0.63) ALDH1A1LMNACYP1A2CYP3A4CYP2D6
SCHEMBL25916150 0.80 ALDH1A1 (0.48) ALDH1A1LMNACYP1A2CYP3A4CYP2D6
SCHEMBL10118553 0.78 CA12 (1.00) ALDH1A1LMNACYP1A2CYP3A4CYP2D6
SCHEMBL15884037 0.78 ALDH1A1 (0.60) ALDH1A1LMNACYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230033450-A1 METHOD FOR PREPARING DIAZOXIDE SOOCHOW UNIVERSITY (CN) 2023-02-02 — — US disclosed
US-8921369-B2 Inhibitors of HCV NS5A PRESIDIO PHARMACEUTICALS, INC. (US) 2014-12-30 — — US disclosed
US-8877707-B2 Inhibitors of HCV NS5A PRESIDIO PHARMACEUTICALS, INC. (US) 2014-11-04 — — US disclosed
US-20130203656-A1 INHIBITORS OF HCV NS5A PRESIDIO PHARMACEUTICALS, INC. (US) 2013-08-08 — — US disclosed
US-20130096101-A1 INHIBITORS OF HCV NS5A PRESIDIO PHARMACEUTICALS, INC. (US) 2013-04-18 — — US disclosed
US-20120122864-A1 INHIBITORS OF HCV NS5A PRESIDIO PHARMACEUTICALS, INC. (US) 2012-05-17 — — US disclosed
WO-2011149856-A1 INHIBITORS OF HCV NS5A PRESIDIO PHARMACEUTICALS, INC. (US) 2011-12-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096101-A1 INHIBITORS OF HCV NS5A HAVCR2, MAVS, EIF2AK2 ALDH1A1 3636/4885LMNA 3893/4885CYP1A2 3701/4885
US-20230033450-A1 METHOD FOR PREPARING DIAZOXIDE DDT, CBS, CTH ALDH1A1 2271/4885LMNA 4771/4885CYP1A2 1371/4885
US-20120122864-A1 INHIBITORS OF HCV NS5A HAVCR2, MAVS, EIF2AK2 ALDH1A1 3492/4885LMNA 3934/4885CYP1A2 3511/4885
US-20130203656-A1 INHIBITORS OF HCV NS5A HAVCR2, MAVS, EIF2AK2 ALDH1A1 3492/4885LMNA 3934/4885CYP1A2 3511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.